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ABSTRACT
Gene silencing techniques, including RNA interference methodologies, are widely used in reverse genetics to study the 
role of specific genes in biological processes. RNA interference has become easier to implement thanks to the RNAi 
Consortium (TRC), which has developed libraries of short hairpin RNA (shRNA) sequences in pseudotyped lentiviral 
particles capable of targeting most genes in the human and mouse genomes. However, a problem is the lack of a 
simple method to titrate the homemade lentiviral particle product, making it difficult to optimize and standardize shRNA 
experiments. Here we provide a guide describing a quick, non-laborious and reliable method for the titration of TRC 
pseudotyped lentiviral particles that is based on the detection and measurement of viral RNA using quantitative PCR. Our 
data demonstrate that purified linearized shRNA plasmids represent more suitable standards than circular or unpurified 
linearized plasmids. We also show that for precise absolute quantification, it is important to determine suitable plasmid 
and viral cDNA concentrations in order to find the linear range for quantification, as well as to reduce inhibition and primer 
dimer amplification. Finally, we show that the lentivirus concentration impacts the level of knockdown in transduced cells. 
Primers utilized in this non-functional titration can potentially be applied to functional titration of proviral DNA copies or 
transgene expression, overcoming problems arising from the absence of fluorescent reporter genes in TRC plasmids.
Keywords: lentiviral particle titer, absolute quantification, shRNA, the RNAi Consortium, RT-qPCR
BACKGROUND
The RNAi Consortium (TRC) has developed genome-scale short 
hairpin (sh)RNA libraries targeting human and mouse genes [1], fa-
cilitating lentiviral-based RNA interference (RNAi). Quantification of 
lentiviruses is important for developing robust and reproducible RNAi 
protocols. Two types of methods have been elaborated to quantify viral 
titers: functional titrations, determining the concentration of viral par-
ticles needed to transduce a cell; non-functional titrations, determining 
the number of viral particles secreted by producer cells.
In the context of functional titration, if a fluorescent reporter gene, 
e.g., green fluorescent protein [2], is transduced alongside the sequence 
of interest, the functional titer can be determined by flow cytometry. 
However, this requires a fluorescent marker and cannot distinguish 
single from multiple proviral DNA integration sites within the host 
genome. An alternative is to estimate the number of integrated provi-
ral DNA copies per cell by quantitative (q)PCR [2]. Because proviral 
copies can be inserted into different chromatin regions, the transgene 
expression can vary [2]. Quantification of the expressed transgene by 
reverse transcription (RT)-qPCR instead of the proviral DNA copies 
gives a closer estimation of the transgene expression [2].
Functional titrations require transduction, which is time-consuming, 
and efficiencies depend on cell type and transgenes [2,3]. Non-functional 
approaches thus present an easier alternative for determining the titer of 
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a lentiviral particle batch for optimization and standardization. These 
methods mostly rely on the measurement of either the expressed viral 
protein p24 or of viral RNA. p24 measured by enzyme-linked immu-
nosorbent assay has reliability issues, due to the presence of a variable 
amount of p24 originating from defective particles and non-particle-as-
sociated p24 [4]. Alternatively, several groups have measured viral 
RNA, either directly by qPCR [5] or indirectly by RT-qPCR [2,4,6,7]. 
Even if viral RNA-based titrations also measure defective particles to 
some extent [6], it has been shown that mainly full-length viral RNA 
transcripts are incorporated into pseudotyped lentiviral particles [4]. To 
our knowledge, only one study has described PCR primers suitable for 
TRC plasmid quantification [7]. However, these primers were within 
the lentiviral capsid sequence, which is not integrated into the host 
genome after transduction, limiting their use to non-functional titration.
Here we develop a descriptive guide for absolute titration of home-
made TRC shRNA pseudotyped lentiviruses by RT-qPCR using TRC 
shRNA plasmids as standards. Plasmid amplification and purification 
followed by pseudotyped lentiviral production take less than 5 d, and 
then 2 d are needed to determine absolute titers (Fig. 1).
We demonstrate that the conformation of the plasmid and its purity 
(circular, linearized or purified linearized) affect qPCR efficiency, and 
that absolute quantification requires both the plasmid and viral cDNAs 
to be within an appropriate concentration range. Designed PCR primers 
are suitable for functional titration via the quantification of integrated 
proviral DNA copies and/or expressed transgene. Moreover, we show 
that lentivirus concentration correlates positively with the level of 
knockdown in transduced cells.
Figure 1. From plasmid amplification to pseudotyped lentiviral particle quantification. Main steps in the timeline of pseudotyped lentiviral particle 
production, starting with plasmid amplification and ending with pseudotyped lentiviral particle absolute quantification.
MATERIALS
Cells
 9 Bacteria: E. coli containing TRC shRNA plasmids [1] (Sig-
ma-Aldrich Mission shRNA SHCLNG, Dorset UK)
 9 Producer cells: Human embryonic kidney (HEK)-293TN cells 
(Cambridge Bioscience LV900A-1, Cambridge UK)
 9 Target cells: HUES7 line (human embryonic stem cells 
(hESCs), Harvard University, hES Cell Facility/Melton Lab-
oratory, MA, USA)
Reagents
 9 0.45 μm syringe filters (Fisher Scientific, cat. # 10460031, 
Loughborough UK)
 9 Activin A (R&D Systems, cat. # 338-AC-050, Abingdon UK)
 9 Agarose (Sigma-Aldrich, cat. # A9539, Dorset UK)
 9 Ampicillin (Sigma-Aldrich, cat. #  A5354, Dorset UK)
 9 β-mercaptoethanol (Invitrogen, cat. # 31350-010, Paisley UK)
 9 B27 serum free supplement (Invitrogen, cat. # 17504-044, 
Paisley UK)
 9 Bovine serum albumin (BSA, Sigma-Aldrich, cat. # A1470-
25G, Dorset UK)
 9 Calcium Phosphate Transfection kit (Sigma-Aldrich, cat. # 
CAPHOS, Dorset UK)
 9 Culture dishes (such as 6-well plates, Corning, cat. # 3506, 
Flintshire UK)
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 9 Distilled nuclease-free water (GIBCO, cat. # 10977-035, 
Paisley UK)
 9 DMEM:F12 (Lonza, cat. # BE12-719F, Cambridge UK)
 9 dNTPs (Invitrogen, cat. # 10297, Paisley UK)
 9 Dry ice
 9 EcoR1 enzyme (New England Biolabs, cat. # R3101S, Herts 
UK)
 9 Envelope vector pM2D.G (Addgene, cat. # 12259, Middlesex 
UK)
 9 Ethanol (Sigma-Aldrich, cat. # 7148, Dorset UK)
 9 FGF2 (prepared in house [8])
 9 Fibronectin (EMD Millipore, cat. # FC010-10MG, Watford 
UK)
 9 Foetal bovine serum (FBS, GIBCO, cat. # 10270-106, Paisley 
UK)
 9 HyperLadder I (Bioline, cat. # BIO-33053, London UK)
 9 HyperLadder V (Bioline, cat. # BIO-33057, London UK)
 9 L-glutamine (Sigma-Aldrich, cat. # G7513, Dorset UK)
 9 N2 serum free supplement (Invitrogen, cat. # 17502-048, 
Paisley UK)
 9 Non-essential amino acids (Invitrogen, cat. # 11140-035, 
Paisley UK)
 9 NT4 (Peprotech, cat. # 450-04, London UK)
 9 Packaging vector psPAX2 (Addgene, cat. #  12260, Middle-
sex UK)
 9 Phenol:Chloroform:Isoamyl alcohol 25:24:1 (Sigma-Aldrich, 
cat. # P3803, Dorset UK)
 9 Primers (synthesised by Sigma-Aldrich, Dorset UK) specific 
to TRC shRNA plasmids for lentiviral absolute quantification: 
forward, 5’-GGGGATTTGGGGTTGCTCTG-3’ and reverse, 
5’-TTCTCTGTCCCACTCCATCCA-3’Primers (synthesised 
by Sigma-Aldrich, Dorset UK) specific to target and house-
keeping genes for knockdown analysis
 9 Puromycin (Gibco, cat. # A11138-03, Paisley UK)
 9 Qiagen plasmid maxi kit (cat. # 12162, Manchester UK)
 9 Qiagen QIAamp viral RNA kit (cat. #52904, Manchester UK)
 9 Random hexamers (Qiagen 79236, Manchester UK)
 9 RQ1 DNase (Promega, cat. #M198A, Southampton UK)
 9 RQ stop buffer (Promega, cat. # M199A, Southampton UK)
 9 Sodium acetate (Sigma-Aldrich, cat. # S5636, Dorset UK)
 9 SuperScript III enzyme (Invitrogen, cat. # 18080-044, Paisley 
UK)
 9 SYBR Green JumpStart Taq ReadyMix (Sigma-Aldrich, cat. 
# S4438, Dorset UK)
 9 Terrific Broth medium (Sigma-Aldrich, cat. # T0918, Dorset 
UK)
 9 TriZOL reagent (Life Technologies, cat. # 15596026, Paisley 
UK)
 9 Trypsin (Sigma-Aldrich, cat. # T4174, Dorset UK)
Recipes
 9 HEK medium: DMEM:F12 supplemented with 2 mM L-glu-
tamine and 10% (v/v) FBS
 9 hESC medium: DMEM:F12 supplemented with 2 mM L-glu-
tamine, 0.1% (w/v) BSA, 1× non-essential amino acids, 0.1 
mM β-mercaptoethanol, 1 × N2, 1 × B27, 40 ng/ml FGF2, 
10 ng/ml Activin A and 4 ng/ml NT4 [9]
 9 Reverse transcription (RT): Three steps: 25°C for 5 min, 50°C 
for 60 min and 70°C for 15 min.
 9 Real-time qPCR: Amplification mixtures: 5 μl of cDNA, viral 
cDNA or purified linearized plasmid, 10 µl of 2 × SYBR 
Green JumpStart Taq ReadyMix, 3 µl of distilled nuclease-free 
water and 1 µl of each primer at 10 µM (final concentration of 
200 nM per reaction). Reaction steps: (1) initial denaturation 
for 3 min at 95°C; (2) 40 cycles of two-step PCR (denaturation 
at 95°C for 10 s, annealing and elongation at 60°C for 30 s); 
and (3) dissociation curve (0.5°C temperature increase every 
5 s, from 65°C to 95°C).
Equipment
 9 –20°C freezer
 9 –80°C freezer
 9 Bio-Rad CFX Connect machine and Bio-Rad CFX Manager 
3.1 software (or any qPCR instrument and software)
 9 Cell incubator
 9 Centrifuge
 9 Nanodrop 2000 (Thermo Scientific, Hemel Hempstead UK)
 9 Shaking incubator for bacteria culture
PROCEDURE
shRNA plasmids: production and optimization as a qPCR standard
1. Plasmid production
1.1. Culture E. coli containing TRC shRNA plasmids overnight in a shaking incubator at 37°C in Terrific 
Broth with ampicillin (100 µg/ml) for selection.
1.2. Purify plasmids using Qiagen plasmid maxi kit and dilute in 200 μl distilled nuclease-free water.
1.3. Measure plasmid concentration and purity using Nanodrop 2000.
NOTE: This step is unnecessary if you buy TRC transfer vectors instead of bacterial strains.
2. Plasmid optimization as a real-time qPCR standard
NOTE: Other types of standards can also be used such as PCR products [10].
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2.1. Plasmid digestion
2.1.1. Digest 500 ng of each plasmid with 1.5 units of EcoR1 for 1 h at 37°C (final volume 25 µl).
2.1.2. Inactivate the enzyme for 20 min at 65°C.
2.1.3. Determine digestion efficacy on a 1% (w/v) agarose gel with the HyperLadder I as molecular 
size marker.
2.2. Plasmid purification
2.2.1. Extraction: add nuclease-free water to the digested plasmids (final volume 100 µl) and one 
volume of phenol:chloroform:isoamyl alcohol. Vortex and centrifuge (15000 g, 2 min) at room 
temperature. Collect the upper aqueous phase containing the nucleic acids into a clean tube.
2.2.2. Precipitation: precipitate plasmids by adding 2.5 × volumes of pure ethanol and 1:10 volume 
of 3 M sodium acetate pH 5.2. Briefly vortex and leave the solution at –80°C for at least 30 
min. Centrifuge (15000 g, 25 min) at 4°C. Discard the supernatant and wash the pellet with 
100 µl 70% (v/v) ethanol. Centrifuge (15000 g, 10 min) at room temperature. Remove the 
supernatant, air-dry the pellet and resuspend in the appropriate amount of nuclease-free water 
(usually 10−20 µl).
NOTE: Three different standard states (different conformations and different purities) were tested: circular plasmids, 
plasmids linearized by EcoR1 digestion and purified linearized plasmids. The results show that only the latter gave 
a reliable and efficient standard (Fig. 2).
3. Store plasmids at –20°C.
TIP: To ensure reproducibility, we advise the determination of standard stability during storage as time and tem-
perature can significantly affect quantification [10].
Pseudotyped lentiviral particle production
4. HEK-293TN transfection:
4.1. Seed HEK-293TN cells at 40% confluence (4 × 104 cells/cm²) in 6 well-plates with 2 ml of HEK 
medium for 6 h at 37°C in a humidified incubator with 5% (v/v) CO2.
4.2. Change cell medium.
4.3. Transiently co-transfect cells using Sigma Calcium Phosphate Transfection kit by adding plasmids of 
the second-generation packaging system at 2 µg/well and at a ratio of 4:2:1 of TRC transfer vector 
[1] (Table S1): Packaging vector psPAX2: Envelope vector pM2D.G.
CAUTION: Manipulating the amount of plasmids (transfer, packaging or envelope) can affect the non-functional 
titer without altering the functional one [11].
4.4. Incubate cells at 37°C in a humidified incubator, 5% (v/v) CO2, for 16 h.
4.5. Change cell medium.
4.6. Incubate cells at 37°C in a humidified incubator, 5% (v/v) CO2, for 48 h.
5. Harvesting supernatant:
5.1. Clear cell medium (containing the secreted pseudotyped lentiviruses) of cell debris by low-speed 
centrifugation (500 g, 10 min) and filter (0.45 μm filters).
5.2. Freeze cell medium aliquots in crushed dry ice.
5.3. Stored at –80°C.
NOTE: Medium from non-transfected HEK-293TN cells was used as a negative control for absolute quantification 
of the pseudotyped lentiviruses.
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Viral RNA extraction, cDNA synthesis and real-time PCR
6. Viral RNA extraction: purify viral RNA from cell medium using Qiagen QIAamp viral RNA kit.
7. cDNA synthesis
7.1. Measure viral RNA concentration using Nanodrop 2000.
NOTE: To verify if the viral RNA was contaminated by RNAs from producer cells, we performed a viral RNA 
extraction on non-transfected HEK-293TN cells. RNAs were detected by Nanodrop 2000 measurement, suggesting 
that exosomes/vesicles containing RNAs were secreted by the HEK-293TN cells [12].
7.2. Treat viral RNA (500 ng) with 1 unit of RQ1 DNase for 30 min.
NOTE: Because HEK-293TN cells were transiently transfected, transfer vector could contaminate the pseudotyped 
lentivirus supernatant. To avoid the amplification of contaminating plasmid DNA, viral RNA was DNase-treated 
prior to RT. This step could be omitted if a stable producer cell line was used instead [13]. DNase-treated viral RNA 
was used as qPCR non-RT (NRT) control to ensure no remaining contamination from plasmid DNA.
7.3. Perform RT according to the supplier instruction by adding 100 ng of DNAfree viral RNA with 200 units 
of SuperScript III enzyme, 200 ng of random hexamers and 10 mM of dNTPs. Assume the reaction 
to be linear and 100% efficient [14].
CAUTION: Use random hexamers and not oligo-dTs, which are unable to bind to viral RNAs due to the absence 
of poly A tails [15].
CAUTION/TIP: RT efficiency can be impacted by different factors such as the type of RT enzyme used [16,17], 
the amount of RNA [17] or its quality (i.e., integrity [18,19] and purity [17]).
7.4. Store viral RNA and cDNA at –80°C.
CAUTION: Storage conditions impact RNA integrity, and therefore, downstream analysis [19].
8. Real-time qPCR:
8.1. Perform real-time qPCR on a qPCR instrument.
NOTE: The pair of primers used to amplify the 124 base pair sequence (Fig. S1) was tested for sequence com-
plementarity against the following human and mouse databases: RefSeq mRNA, Genome, NCBI Chromosome 
Sequences, Transcript Reference Sequences and Nucleotide Collection. As expected, they were highly specific to 
the HIV-1 integration site (data not shown). Other predicted PCR products were too large to be amplified by our 
qPCR reaction conditions (data not shown).
NOTE: Primers were designed against the sequence element of the shRNA plasmid that is integrated into the 
host genome after transduction. Specifically, they are located immediately following the Rev response element se-
quence (Fig. S1). Even though this was not within the scope of our research, these primers can be potentially used 
for functional titration of both integrated proviral DNA copies and expressed transgene before complete splicing, 
overcoming the fact that the shRNA plasmids do not contain a fluorescent reporter gene [1].
8.2. Perform qPCR in triplicate using a range of different plasmid concentrations.
NOTE: 12 concentrations were tested, from 0.3 pg/reaction to 5 ng/reaction.
CAUTION: The workable concentration range of the standard plasmid is an important parameter: very high 
template concentrations can interfere with the qPCR reaction and decrease its efficiency (E), whereas very low 
template concentrations can result in primer dimer formation.
8.3. Perform qPCR in triplicate using serial dilutions of viral cDNA from untransfected (negative control) 
and transfected HEK-293TN.
NOTE: 5 concentrations were tested, from 0.6 to 7.5 ng/reaction (2 × serial dilution).
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CAUTION: The workable concentration range for qPCR is a key parameter: low viral cDNA concentrations tend 
to overestimate the absolute number of pseudotyped lentiviruses due to the presence of primer dimers, whereas 
high viral cDNA concentrations can inhibit the PCR, resulting in the number of lentiviruses being underestimated.
8.4. Perform ‘no reverse transcription’ (NRT) and ‘no template controls’ (NTC) to confirm absence of 
contamination.
8.5. Run qPCR products on a 2.5% (w/v) agarose gel with the HyperLadder V as molecular size marker 
to verify product sizes.
NOTE: qPCR product specificity is validated by comparing qPCR product melting peak and gel electrophoresis 
of the viral cDNA templates with NRT, NTC and negative controls.
Lentiviral particle absolute quantification
9. Construct standard curves
9.1. Use purified linearized plasmids as standards for absolute quantification.
9.2. Extract raw qPCR data.
9.3. Use the concentrations yielding the best technical replicates in terms of their similarity of signal and 
the absence of primer dimers (checked using melting peak data) to generate standard curves.
10. Determine qPCR amplification efficiencies (E)
10.1. Plot cycle threshold (Ct) values of the standard dilutions against the logarithm of N (the number of 
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NOTE: A factor of 2 is applied to N to take into account that plasmids are double-stranded while viral RNA and 
cDNA are single-stranded.
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11. Use the same standard curves to establish the pseudotyped lentiviral particle absolute titer as follows:
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NOTE: Each lentivirus carries two RNA copies implying a theoretical ratio of ½ [22].
TIP: To better estimate the absolute titer, more than one cDNA concentration was utilized to calculate the final 
quantification.
Cell culture, transduction and knockdown analysis
NOTE: This section uses hESCs as a model cell line but other cell lines could be used instead.
12. Cell culture:
12.1. Coat culture dishes with 100 μl/cm2 fibronectin at 25 μg/ml for 1 h at 37°C.
12.2. Culture the hESCs in a serum-free and feeder cell-free preparation developed in our laboratory [9] 
and incubate them at 37°C in a humidified incubator with 5% (v/v) CO2.
NOTE: Other hESC growth medium may be used.
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12.3. Change culture medium every two days.
12.4. Passage cells every three to five days by trypsinization (50 μl of 0.5 ×  trypsin/cm2).
13. Cell transduction
At day 0:
13.1. Seed hESCs at 2600 cells/cm².
13.2. Incubate cells at 37°C in a humidified incubator, 5% (v/v) CO2, for 6 h.
13.3. Add lentiviruses to the cell medium.
NOTE: Concentrations of 18 pg viral RNA/cell (C1) and 36 pg viral RNA/cell (C2) were used in the present study.
CAUTION: For different shRNAs, equivalent amounts of extracellular RNA may not equate to equivalent con-
centrations of the respective lentiviruses.
At day 1:
13.4. Change cell medium.
13.5. Incubate cells for two more days.
At day 3:
13.6. Passage cells.
13.7. Add puromycin to the medium at a concentration of 0.5 μg/ml for selection.
At day 5:
13.8. Lyse cells for RNA extraction using TriZOL reagent.
13.9. Store lysates at −80°C or perform RNA extraction (see the following section).
14. Knockdown analysis
14.1. RNA extraction
14.1.1. Purify RNA by chloroform extraction (1:5 of TriZOL volume, 10 min incubation at room tem-
perature, 15 min centrifugation at 12000 g, 4°C) and isopropanol precipitation (1:2 of TriZOL 
volume added to the aqueous phase, 10 min incubation at room temperature, 15 min centrifu-
gation at 12000 g, 4°C).
14.1.2. Wash RNA pellets with 75% (v/v) ethanol (1:1 of TriZOL volume, 15 min centrifugation at 
12000 g, 4°C).
14.1.3. Dissolve RNA pellets in 25 to 100 µl of distilled nuclease-free water.
14.1.4. Measure RNA concentration and purity using Nanodrop 2000.
14.1.5. Store RNAs at −80°C.
CAUTION: Storage conditions impact RNA integrity and, therefore, downstream analysis [19].
14.2. cDNA synthesis:
14.2.1. Treat RNA (1 µg) with 1 unit of RQ1 DNase for 30 min.
14.2.2. Stop the reaction by adding 1 µl of RQ stop buffer followed by a 15-min incubation at 60°C.
14.2.3. Perform RT according to the supplier instruction by adding 200 ng of DNase-treated RNA with 
200 units of SuperScript III enzyme, 200 ng of random hexamers and 10 mM of dNTPs. Assume 
the reaction to be linear and 100% efficient [14].
CAUTION/TIP: RT efficiency can be impacted by different factors such as the type of RT enzymes used [16,17], 
the amount of RNA [17], RNA quality (integrity [18,19] and purity [17]) and the priming strategy [23].
14.2.4. Store cDNA at −80°C.
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14.3. Real-time qPCR:
14.3.1. Design PCR primers with NCBI primer-BLAST online tool [24] to amplify all variant transcripts 
of each target gene with the following parameters: PCR product size between 60 and 150 base 
pairs, melting temperature (Tm) at 60.0°C ± 1.0°C with a maximum Tm difference of 1.0°C and 
primers spanning an exon-exon junction or being separated by at least one intron if possible.
14.3.2. Perform real-time qPCR on target and housekeeping genes. Run each sample in triplicate.
NOTE: In the present study, target genes were neuropilin 1 (NRP1), plexin B1 (PLXNB1) and octamer-binding 
transcription factor 4 (OCT4, protein encoded by Pit-1 octamer unc-86 class 5 homeobox 1, abbreviated Pou5f1), 
and housekeeping genes were HPRT1, MAPK1 and UBC (Table S2).
CAUTION:
 9 qPCR primer efficiency should be assessed [25].
 9 Housekeeping gene stability should be assessed and validated by a coefficient of variance  < 0.5 and the 
M-value  < 1 [26].
 9 Each qPCR plate should contain a calibrator (two wells with the same cDNA in each plate) to mitigate plate-
to-plate variability in the analysis.
 9 NRT and NTC should be performed to confirm absence of contamination.
 9 If the Ct standard error of the mean (SEM) is > 0.25, the outlier Ct should be removed from the analysis, or 
the sample should be rerun.
14.4. Relative quantification: extract raw qPCR data and calculate the relative quantification using the 
method [27].
NOTE: Raw qPCR data were extracted and analyzed with Bio-Rad CFX Manager 3.1 software in the present 
study. Statistical analysis was performed using IBM SPSS Statistics 21 software.
14.5. Correlation between knockdown and shRNA lentiviral concentration:
14.5.1. Convert viral RNA concentration into number of viral particles if need be.
14.5.2. Plot the knockdown percentage as a function of the absolute number of viral particles (plot each 
target gene independently).
14.5.3. Use a logarithmic fitting curve to describe the correlation.
ANTICIPATED RESULTS
Optimization of the qPCR standard
To obtain a precise and accurate measurement of the absolute titer 
of pseudotyped lentiviral particles, real-time qPCR standards have to 
be as reliable and efficient as possible. According to our results, when 
using plasmids as standard, the purified linearized form was the most 
appropriate, with a qPCR efficiency (E) of 84% and 73% in the given 
examples (Fig. 2A and 2B). For circular plasmids, E was 37% and 
43%, suggesting that the circular shape had a negative effect on the 
PCR reaction. The PCR reaction was also inhibited when the linearized 
plasmid was not purified (E = 38% and 32%).
The workable concentration range for qPCR also needs to be es-
tablished by: (1) verifying the absence of primer dimers (especially 
for the low cDNA concentrations, from 0.3 pg/μl in the present case) 
using qPCR product melting peaks (Fig. 2C) and gel electrophoresis 
(Fig. 2D); (2) checking if the highest cDNA concentration(s) lower E. 
Our data demonstrated that removing the two highest tested plasmid 
concentrations of 5 ng/µl and 1 ng/μl improved E by 19% ± 8% (Fig. 
2B-2E, Table 1, Fig. S2).
Specificity of the real-time qPCR
Viral RNA should be DNase-treated prior to RT to avoid quantification 
bias due to contaminant plasmids from transfected HEK-293TN cell 
medium. The real-time qPCR must contain the following controls: (1) 
cDNA from viral RNA of untransfected HEK-293TN cell medium as 
negative control; (2) DNase-treated viral RNA as NRT and (3) NTC. 
The qPCR melting peaks, as well as gel electrophoresis of the controls 
were compared to those from samples for assessing product specificity 
(Fig. 3A-3F). None of the tested cDNA concentrations from non-trans-
fected HEK-293TN cells gave a specific amplification of our product 
of interest (Fig. 3D-3F).
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Table 1. Standard efficiencies. 
shControl shCDH8 shNRP1-24 shOCT4-79 shPLXNB1-35 shSERPINE1 Mean SEM
A 0.63 0.79 0.75 0.64 0.70 0.75 0.71 0.06
B 0.76 0.88 0.85 0.71 0.75 0.83 0.80 0.07
C 0.78 0.99 0.91 0.99 0.82 0.92 0.90 0.09
Calculated efficiencies of six different purified and linearized shRNA plasmids. A: with the both highest tested concentrations; B: without the highest con-
centration of 5 ng/reaction; C:  without the both highest tested concentrations of 5 and 1 ng/reaction.
Figure 2. qPCR efficiencies and dynamic range of the standard curves. A. Efficiency curves of circular (red), linearized (orange) and purified linearized 
(blue): shOCT4-79 (left panel) and shControl plasmids (right panel). Linear regression curves are given with their correlation coefficient R2. The purified 
linearized plasmids give a slope of -4.01 and -4.18 respectively, which are the closest to -3.32, the ideal slope resulting in an amplification efficiency of 
100%. Examples of amplification curves (B), melting peaks (C) and agarose gel of qPCR products from the shSERPINE1 (D) purified linearized standard. 
The tested plasmid concentration range is represented: the highest in orange, the intermediate in green and the lowest in red. E. Efficiency curves of 
purified linearized shSERPINE1 standard with the two highest plasmid concentrations (purple), without the highest concentration of 5 ng/reaction (green) 
or without the both highest tested concentrations of 5 and 1 ng/reaction (blue). Linear regression curves are given with their correlation coefficient R2. 
The blue curve gives a slope of -3.52 which is the closest to -3.32, the ideal slope resulting in an amplification efficiency of 100%.
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Figure 3. shRNA pseudotyped lentiviral particle absolute quantification. A-C. Viral cDNA quantification by qPCR: examples of amplification curves 
(A), melting peaks (B) and agarose gel of qPCR products from the shPLXNB1 viral cDNA (C). The viral cDNA concentration in green was the highest 
tested and in orange the lowest. The NRT is represented in red. D-F. cDNA amplification from non-transfected producer cells: amplification curves (D), 
melt peaks (E) and agarose gel of qPCR products from amplified cDNA of purified secreted RNA of HEK-293TN cells in orange, an example of amplified 
shOCT4-79 plasmid in green and NTC in red (F). G-H. Effect of the lowest and highest viral cDNA concentrations on shRNA pseudotyped lentiviral 
particle absolute quantification: comparisons of shRNA lentiviral particle absolute quantification using intermediate (medium) and the lowest (G) or the 
highest (H) viral cDNA concentrations (pseudotyped lentiviral particles/µl of supernatant, mean ± SEM; shNRP1=shNRP1-24; shOCT4=shOCT4-79; 
shPLXNB1=shPLXNB1-35).
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Figure 4. Effect of shRNA lentiviral concentration on knockdown efficiency. A. Relative gene expression results measuring the knockdown efficiency 
of NRP1, PLXNB1 and OCT4 with two different shRNA concentrations C1 (18 pg viral RNA/cell) and C2 (36 pg viral RNA/cell. Only C2 was used for 
shControl ( normalisation done against untransduced hESCs; mean ± SEM; One sample t-test, *0.01 < P < 0.05, ***P < 0.001, N.S.: not significant, no 
star means n < 3). B-E. Correlations (logarithmic fitting curves) between the amount of shRNA lentiviral particles (absolute number) and the knockdown 
efficiency (%) of NRP1 (purple), PLXNB1 (red) and OCT4 (orange) together or separately.
Absolute quantification of the pseudotyped lentiviral 
particle
Similarly to the plasmids, our data demonstrate that it is very im-
portant to determine the workable concentration range suitable for 
viral cDNA amplification. Low viral cDNA concentrations resulted 
in non-specific amplification of primer dimers (Fig. 3A-3C), leading 
to an overestimation of the absolute number of pseudotyped lentiviral 
particles (Fig. 3G). High viral cDNA concentration led to PCR reac-
tion inhibition and, therefore, to the underestimation of the absolute 
number of pseudotyped lentiviral particles (Fig. 3H). Because the 
suitable concentration range for titration was limited (usually between 
1 and 7.5 ng/reaction maximum), calculating the cDNA amplification 
efficiency was not relevant.
shRNA lentiviral concentration and knockdown, a cor-
relation
The highest viral RNA concentration triggered higher knockdowns 
(Fig. 4A), but no correlation was apparent between RNA concentration 
and knockdown efficacy. This may be due to the measurement of lenti-
viral shRNA concentration in terms of extracellular RNA, which may 
be confounded by contributions from cellular RNAs. Thus, for different 
shRNAs, equivalent amounts of extracellular RNA may not equate to 
equivalent concentrations of the respective lentiviruses. In contrast, when 
the conversion into absolute number of viral particles was done using 
the method described above (Fig. 1), there was a positive correlation 
with the knockdown efficacy (Fig. 4B). Target genes were expressed 
at different levels in hESCs in terms of qPCR Ct range: OCT4 (21.5 
< Ct < 26.5, control cells; 26 < Ct < 39, knockdown cells) was more 
highly expressed than NRP1 (27.5 < Ct < 31.5, control cells; 27 < Ct 
< 33, knockdown cells), which was highly expressed than PLXNB1 
(30.5 < Ct < 36.5, control cells; 33 < Ct < 39, knockdown cells). Con-
sequently, the correlation was stronger when each gene was analyzed 
individually (Fig. 4C-4E). The differences in knockdown efficiency 
might be linked to the expression level of each gene [28] and/or to the 
shRNA sequences themselves [29]. Moreover, the correlation seemed 
to be more logarithmic than linear, which is consistent with published 
results of expressed transgene quantification by RT-qPCR in mesen-
chymal stem cells [30].
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TROUBLESHOOTING Table 2 recapitulates the main sensitive points for achieving a reliable 
absolute quantification of produced lentiviral particles.
Table 2. Troubleshooting table. 
Step Sensitive point(s)
Optimization of the real-time 
qPCR standard
If using a plasmid as standard, prefer the purified linearized state
Run agarose gels to verify plasmid digestion
Determine good conditions for the standard storage (over time and temperature) [10]
Determine the workable concentration range for qPCR
(Too high = decrease of E; Too low = formation of primer dimers)
Pseudotyped lentiviral particle 
production
Manipulating the amount of any plasmid (transfer, packaging or envelope) can affect the non-functional titer without 
altering the functional one [11]
Specificity of the real-time 
qPCR
Viral RNA purification:
Perform a viral RNA extraction on non-transfected HEK-293TN cells to use as a negative control
Do a DNase treatment of the pseudotyped lentiviral particle supernatant prior to reverse transcription to degrade 
potential plasmid left-overs during transient transfection
Real-time qPCR:
If using a novel pair of primers, test their complementary against suitable databases (Refseq mRNA, etc.)
Use suitable qPCR controls (e.g. NRT, NTC*)
Construct the qPCR dissociation curves
Run agarose gels to verify qPCR product sizes
Pseudotyped lentiviral particle 
absolute quantification
Determine the workable concentration range for qPCR
(Too high = PCR inhibition and decrease of E, leads to an underestimation of the absolute number of produced parti-
cles;
Too low = formation of primer dimers, leads to an overestimation of the absolute number of produced particles)
Use more than 1 viral cDNA concentration for calculation
Cell culture, transduction and 
knockdown analysis
Prefer the use of absolute number of viral particles as metrics rather than viral RNA concentration to standardize 
knockdown experiments
 *NRT: no reverse transcription; NTC: no template controls.
CONCLUSIONS
Many studies have demonstrated that shRNA lentiviral-based ap-
proaches provide efficient and stable knockdown in various cell types. 
The present guide is a simple way to non-functionally quantify the 
absolute number of produced pseudotyped TRC shRNA lentiviral 
particles in a batch. The quantification can be used prior to transduc-
tion for protocol standardization and optimization, such as finding the 
best producer cell line or investigating the optimal harvesting period. 
Moreover, this non-functional titration rapidly provides insight into the 
knockdown efficacy that can be achieved, without doing a functional 
titration. The same primer pair can potentially be used for functional 
titration of both the integrated proviral DNA copies and the expressed 
transgene level in mouse and human cells.
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